What Does Dexamethasone Deplete? 7 Nutrients Affected
Taking this medication? Check what it depletesFree, 10 seconds →
Depletions Overview
Calcium
HighDexamethasone reduces intestinal calcium absorption by antagonizing vitamin D-dependent transport proteins, while simultaneously increasing renal calcium excretion through direct effects on kidney tubular handling. According to CTD data linking dexamethasone to 404 curated disease associations including osteonecrosis, the calcium depletion pathway operates through both reduced intake and increased output, making bone density loss one of the most significant consequences of corticosteroid use.
Vitamin D
HighDexamethasone accelerates vitamin D metabolism through CYP enzyme induction and reduces vitamin D receptor sensitivity in target tissues. According to 11,540 gene interactions cataloged in CTD for dexamethasone, the glucocorticoid receptor activation affects virtually every vitamin D-dependent pathway. This creates a compounding effect with calcium depletion because vitamin D is required for intestinal calcium absorption, meaning both nutrients decline simultaneously through interconnected mechanisms.
Potassium
Moderate-HighDexamethasone's mineralocorticoid activity promotes sodium retention and potassium excretion through the kidney's collecting duct, activating ENaC channels and potassium secretion. According to ChEMBL mechanism-of-action data classifying dexamethasone as a glucocorticoid receptor agonist, this mineralocorticoid cross-reactivity is a class effect that becomes clinically significant with higher doses and longer courses. Dexamethasone has less mineralocorticoid activity than prednisone but still causes meaningful potassium loss.
Magnesium
ModerateDexamethasone increases renal magnesium excretion through mineralocorticoid-mediated effects on tubular handling. Across 26,614 PubMed-indexed articles on dexamethasone, magnesium loss compounds potassium depletion because the kidney cannot retain potassium effectively when magnesium is low. Glucocorticoid-induced stress responses further accelerate magnesium excretion through catecholamine-driven renal wasting.
Zinc
ModerateDexamethasone increases urinary zinc excretion through glucocorticoid-mediated effects on renal zinc handling. According to PharmGKB annotations linking dexamethasone to ABCB1 and CTLA4 genes affecting drug transport and immune regulation, zinc depletion compounds the immune suppression that is already a primary concern with corticosteroid therapy. Low zinc impairs wound healing in patients who often need it most.
Vitamin C
ModerateDexamethasone increases both utilization and urinary excretion of vitamin C. Glucocorticoids generate oxidative stress that consumes antioxidant reserves, while simultaneously accelerating vitamin C clearance through the kidneys. According to CTD data documenting 21,866 disease associations for dexamethasone, the oxidative stress pathway affects tissue repair and immune function. Vitamin C depletion further impairs the wound healing that is already compromised by corticosteroid therapy.
Chromium
ModerateDexamethasone increases urinary chromium excretion while simultaneously driving insulin resistance through glucocorticoid receptor activation. Chromium is an essential cofactor for insulin signaling, and its depletion compounds the steroid-induced diabetes that is a major concern with corticosteroid therapy. According to 917 randomized controlled trials involving 868,129 patients in dexamethasone research indexed by CTD, glucose dysregulation is among the most common metabolic side effects.
Wondering about YOUR specific medications?
Check free — no signup, 10 seconds →How It Causes Depletions
Dexamethasone is a synthetic glucocorticoid prescribed to approximately 8 million Americans annually under brand names Decadron and DexPak for severe inflammation, cerebral edema, chemotherapy-induced nausea, severe COVID-19, preterm labor fetal lung maturation, and Cushing's syndrome diagnosis. According to ChEMBL mechanism-of-action data, dexamethasone is a glucocorticoid receptor agonist approximately 25-30 times more potent than cortisol, with Phase 4 indications spanning eye diseases, neoplasms, Crohn's disease, diabetic retinopathy, and laryngeal edema. With oral bioavailability of 74%, 77% protein binding, a plasma half-life of 4 hours but a biological duration of action of 36-54 hours, and a volume of distribution of 51 liters, dexamethasone's potent glucocorticoid activity persists far longer than its plasma presence suggests, meaning nutrient depletion pathways remain active throughout its extended biological half-life.
The Comparative Toxicogenomics Database catalogs 11,540 gene interactions for dexamethasone, with 21,866 total disease associations and 404 curated disease links — the largest molecular footprint of any medication in Kelda's database by a significant margin. This extraordinary gene interaction count reflects dexamethasone's role as a glucocorticoid receptor agonist — the glucocorticoid receptor is a nuclear transcription factor that, when activated, binds to glucocorticoid response elements across thousands of genes throughout the genome. The 7 nutrient depletions flow from this broad transcriptional activation: calcium and vitamin D depletion occur through reduced intestinal absorption and increased renal excretion, potassium and magnesium loss through mineralocorticoid cross-reactivity, zinc through increased urinary excretion, vitamin C through oxidative stress consumption, and chromium through renal wasting compounded by insulin resistance.
PharmGKB pharmacogenomic annotations include 10 entries for dexamethasone, linking genes including ABCB1, CTLA4, CTNNB1, PYGL, and SERPINE1 to drug efficacy and toxicity in conditions including multiple myeloma, acute lymphoblastic leukemia, and osteonecrosis. Across 917 randomized controlled trials involving 868,129 patients in dexamethasone research indexed by CTD, the evidence base spans oncology, immunology, pulmonology, and critical care. Across 212 million rows in Kelda's database, dexamethasone's 7-nutrient depletion profile is the broadest of any single medication, and its 11,540 gene interactions explain why corticosteroid side effects affect virtually every organ system. The calcium-vitamin D-bone density cascade is the most clinically significant, with steroid-induced osteoporosis affecting a substantial proportion of long-term users, but the chromium-insulin-glucose pathway is equally important because steroid-induced diabetes can persist after the medication is discontinued.
Symptoms to Watch For
Dexamethasone depletes 7 nutrients simultaneously through its broad glucocorticoid receptor activation, which affects gene expression across thousands of pathways. Calcium and vitamin D deplete first within weeks, followed rapidly by potassium, magnesium, and vitamin C. Zinc and chromium deplete more gradually over months. Many of these symptoms overlap with the conditions dexamethasone is prescribed to treat — inflammation-related pain, fatigue, immune suppression — making it difficult to distinguish medication side effects from underlying disease without targeted blood testing.
What to Monitor
Request these at your next appointment. Check the ones you want to remember.
What vs Others
| Name | Depletions | Potency | Notes |
|---|---|---|---|
| DexamethasoneThis drug | 7 nutrients | Very High | 25-30x cortisol potency, 11,540 CTD gene interactions, 36-54h biological half-life despite 4h plasma half-life |
| Prednisone | 7 nutrients | Moderate-High | Most commonly prescribed oral corticosteroid, 4x cortisol potency, more mineralocorticoid activity than dexamethasone |
| Prednisolone | 7 nutrients | Moderate-High | Active form of prednisone, same depletion profile, preferred in liver impairment where prednisone conversion may be reduced |
All corticosteroids deplete the same 7 nutrients through glucocorticoid receptor activation, but potency and mineralocorticoid cross-reactivity vary. Dexamethasone is 25-30x more potent than cortisol with less mineralocorticoid activity than prednisone, meaning slightly less sodium retention and potassium loss per equivalent anti-inflammatory dose. According to CTD data, dexamethasone's 11,540 gene interactions dwarf prednisone's profile, reflecting its higher receptor binding affinity and broader transcriptional effects.
Food Sources for Depleted Nutrients
| Food | Amount per Serving |
|---|---|
| Sardines with bones | 351mg per 3.75oz can |
| Yogurt (plain) | 296mg per cup |
| Kale (cooked) | 177mg per cup |
| Fortified plant milk | 300mg per cup |
| Broccoli (cooked) | 62mg per cup |
Source: USDA Food Composition Database (658,209 food nutrient entries)
FAQ
References
- [1]Comparative Toxicogenomics Database (CTD): 11,540 dexamethasone gene interactions, 21,866 disease associations, 404 curated disease links (accessed April 2026)
- [2]ChEMBL Database: Dexamethasone classified as glucocorticoid receptor agonist, Phase 4 indications for eye diseases, neoplasms, Crohn's disease, diabetic retinopathy, acne, and laryngeal edema (accessed April 2026)
- [3]PharmGKB Database: 10 pharmacogenomic annotations for dexamethasone linking ABCB1, CTLA4, CTNNB1, and SERPINE1 to drug efficacy and toxicity (accessed April 2026)
- [4]PubMed: 26,614 indexed articles for dexamethasone; 917 randomized controlled trials across 868,129 patients (accessed April 2026)
- [5]FAERS Database: Adverse event reporting for dexamethasone including steroid-induced diabetes, osteoporosis, and immunosuppression (accessed April 2026)
- [6]Kelda Health Intelligence Platform: Cross-referenced analysis across 212 million rows integrating CTD, ChEMBL, FAERS, PharmGKB, and PubMed datasets (accessed April 2026)
Check your medications
Check Free →